USE OF PFIZER’S COVID ANTIVIRAL DRUG INCREASED 315%: U.S. HEALTH DEPARTMENT
Wed 18 May 2022: Paxlovid, a COVID-19 oral antiviral treatment developed by Pfizer Inc, has seen a 315 percent increase in use in the last four weeks, according to the US Department of Health and Human Services. According to a senior health official, about 115,000 courses of the drugs were distributed in the first week […]
Continue Reading
